{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T23:29:27Z","timestamp":1790033367313,"version":"4.0.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1038\/mt.2016.186","type":"journal-article","created":{"date-parts":[[2016,11,7]],"date-time":"2016-11-07T02:17:20Z","timestamp":1478485040000},"page":"1710-1711","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Preliminary Reports of Stereotaxic Stem Cell Transplants in Chronic Stroke Patients"],"prefix":"10.1016","volume":"24","author":[{"given":"Cesar V","family":"Borlongan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2016.186_bib1","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0140-6736(16)30513-X","article-title":"Human neural stem cells in patients with chronic ischaemic stroke (PISCES): a phase 1, first-in-man study","volume":"388","author":"Kalladka","year":"2016","journal-title":"Lancet"},{"key":"10.1038\/mt.2016.186_bib2","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1161\/STROKEAHA.116.012995","article-title":"Clinical outcomes of transplanted modified bone marrow-derived mesenchymal stem cells in stroke: a phase 1\/2a study","volume":"47","author":"Steinberg","year":"2016","journal-title":"Stroke"},{"key":"10.1038\/mt.2016.186_bib3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.expneurol.2005.12.011","article-title":"A conditionally immortal clonal stem cell line from human cortical neuroepithelium for the treatment of ischemic stroke","volume":"199","author":"Pollock","year":"2006","journal-title":"Exp Neurol"},{"key":"10.1038\/mt.2016.186_bib4","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1172\/JCI200420935","article-title":"Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation","volume":"113","author":"Dezawa","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2016.186_bib5","first-page":"1612","article-title":"Death but one unintended consequence of gene-therapy trial","volume":"164","author":"Sibbald","year":"2001","journal-title":"CMAJ"},{"key":"10.1038\/mt.2016.186_bib6","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1177\/1545968309335978","article-title":"The neural stem cell line CTX0E03 promotes behavioral recovery and endogenous neurogenesis after experimental stroke in a dose-dependent fashion","volume":"23","author":"Stroemer","year":"2009","journal-title":"Neurorehabil Neural Repair"},{"key":"10.1038\/mt.2016.186_bib7","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1089\/scd.2009.0011","article-title":"Notch-induced rat and human bone marrow stromal cell grafts reduce ischemic cell loss and ameliorate behavioral deficits in chronic stroke animals","volume":"18","author":"Yasuhara","year":"2009","journal-title":"Stem Cells Dev"},{"key":"10.1038\/mt.2016.186_bib8","doi-asserted-by":"crossref","first-page":"e50444","DOI":"10.1371\/journal.pone.0050444","article-title":"Human neural progenitor cell engraftment increases neurogenesis and microglial recruitment in the brain of rats with stroke","volume":"7","author":"Hassani","year":"2012","journal-title":"PLoS One"},{"key":"10.1038\/mt.2016.186_bib9","doi-asserted-by":"crossref","first-page":"e74857","DOI":"10.1371\/journal.pone.0074857","article-title":"Stem cell recruitment of newly formed host cells via a successful seduction? Filling the gap between neurogenic niche and injured brain site","volume":"8","author":"Tajiri","year":"2013","journal-title":"PLoS One"},{"key":"10.1038\/mt.2016.186_bib10","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2202-10-86","article-title":"c-MycERTAM transgene silencing in a genetically modified human neural stem cell line implanted into MCAo rodent brain","volume":"10","author":"Stevanato","year":"2009","journal-title":"BMC Neurosci"},{"key":"10.1038\/mt.2016.186_bib11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1742-2094-8-133","article-title":"Comparing the immunosuppressive potency of na\u00efve marrow stromal cells and Notch-transfected marrow stromal cells","volume":"8","author":"Dao","year":"2011","journal-title":"J Neuroinflammation"},{"key":"10.1038\/mt.2016.186_bib12","doi-asserted-by":"crossref","first-page":"SI29","DOI":"10.1016\/S0140-6736(99)90229-5","article-title":"Neural transplantation for neurodegenerative disorders","volume":"353 (suppl. 1)","author":"Borlongan","year":"1999","journal-title":"Lancet"},{"key":"10.1038\/mt.2016.186_bib13","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.5966\/sctm.2013-0178","article-title":"Intra-arterial immunoselected CD34+ stem cells for acute ischemic stroke","volume":"3","author":"Banerjee","year":"2014","journal-title":"Stem Cells Transl Med"},{"key":"10.1038\/mt.2016.186_bib14","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1161\/STROKEAHA.114.007028","article-title":"Intravenous autologous bone marrow mononuclear stem cell therapy for ischemic stroke: a multicentric, randomized trial","volume":"45","author":"Prasad","year":"2014","journal-title":"Stroke"},{"key":"10.1038\/mt.2016.186_bib15","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/STROKEAHA.114.007105","article-title":"One, two, three steps toward cell therapy for stroke","volume":"46","author":"Diamandis","year":"2015","journal-title":"Stroke"},{"key":"10.1038\/mt.2016.186_bib16","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-2184.2008.00486.x","article-title":"Stem cells and neurological diseases","volume":"41","author":"Hess","year":"2008","journal-title":"Cell Prolif"},{"key":"10.1038\/mt.2016.186_bib17","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1586\/14737175.2015.1021787","article-title":"Developments in intracerebral stem cell grafts","volume":"15","author":"Reyes","year":"2015","journal-title":"Expert Rev Neurother"},{"key":"10.1038\/mt.2016.186_bib18","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0140-6736(16)31259-4","article-title":"Age of PISCES: stem-cell clinical trials in stroke","volume":"388","author":"Borlongan","year":"2016","journal-title":"Lancet"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616454006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616454006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:51:01Z","timestamp":1761501061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616454006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":18,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S1525001616454006"],"URL":"https:\/\/doi.org\/10.1038\/mt.2016.186","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preliminary Reports of Stereotaxic Stem Cell Transplants in Chronic Stroke Patients","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/mt.2016.186","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American Society of Gene & Cell Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}